A M Pappas & Associates
Abingworth Management
ACE BioSciences
Adamant Biomedical Investments
Advent Venture Partners
AFX News
Agendia
Agendia
Albany Venture Managers
Alice Ventures
Alliance Pharma
AlpInvest Partners
Alta Berkeley
Alta Partners
APM News
Apoxis
Ardana
Atlas Venture
Austrianova
Avax Technologies, Inc.
Avidex
Avista Capital Partners
Avlar Bioventures
Bank Sarasin
BankInvest Group
Beattie Financial
Beer and Partners
Biobase
BioCentury
Biophan Technologies
Biopure Corporation
BioScience Managers
Biotech International
Bloomsbury BioSeed Fund
Buchanan Communications
Canaccord Capital Corporation
CEC Europe, Pharma
Chemistry & Industry Magazine
Chemokine Therapeutics Corp
Clear Capital
Clubb Capital
Code Securities
Coller Capital
Collins Stewart
Credit Agricole Private Equity
Credit Suisse First Boston
D'Arcy West Ventures
deCODE chemistry  & deCODE biostructures
Deloitte & Touche
Deloitte & Touche
Deutsche Bank
DJG Advisors
Dow Jones
Dow Jones Newsletters
Dow Jones Newswires
Drug Discovery World
Dryden Wealth Management
Dundas & Wilson
DyoDelta Biosciences
Earlybird Ventures
East Hill Management Company
Eden Financial
Edison Investment Research
Edmond de Rothschild Investment  Partners
ESBATech
Esperante
European Biopharmaceutical Review
Evolutec
Evolution Securities Ltd
FaustPharmaceuticals
Ferghana Partners
Financial Dynamics
Financial Times
Genetic Engineering News
Global Life Science Ventures
GLYCART Biotechnology
Grant Thornton UK LLP
Growth Company Investor
Heidelberg Pharma GmbH
Index Ventures
Innate Pharma
Innoven Partenaires
Insinger de Beaufort
Intercytex
Investors Chronicle
ITX Corporation
Javelin Ventures
Jefferies International
JM Finn & Co
JP Morgan
Karolinska Investment Fund
KBC Peel Hunt
Lehman Brothers
Lehman Brothers
Lombard Odier Darier Hentsch
MASA Life Science Ventures
Merrill Lynch
mondoBIOTECH
Morgan Lewis
Morgan Stanley
Nature Publishing Group
Newron Pharmaceuticals
Nextech Venture
Nomura Phase4 Ventures
Numis Securities
NW Brown Capital Partners
Oakes, Lyman & Co
Objective Capital
Omega Fund
Oxford Finance Corporation
Oxford Genome Sciences
Panmure Gordon
Paradigm Therapeutics
Paul Capital Partners
PediaMed Pharmaceuticals
Pharmaprojects
Phytopharm
PolyTechnos Venture Partners
PowderMed
Private Equity - Investments & Advisory Services
Quintiles PharmaBio
Reabourne Technology Investment Management Limited
Scottish Equity Partners
Scottish Widows Investment Partnership
Scrip World Pharmaceutical News, PJB Publications
Seymour Pierce
Sitka
Sofinnova
South East Growth Fund
Spectrum Pharmaceuticals, Inc.
Speedel Pharma
Strata Partners
Strathdon Investments
SV Life Sciences
Symphogen
Teather & Greenwood
The Rainbow Seed Fund
The Ruth Group
The Wellcome Trust
Warburg Pincus
Wellington Partners Venture Capital
Williams de Broe
Windhover Information Inc  - In Vivo Start Up
Zealand Pharma